| Literature DB >> 15741683 |
Kotaro Nishida1, Minoru Doita, Toru Takada, Takatoshi Shimomura, Koichiro Maeno, Ken-ichiro Kakutani, Hiroshi Miyamoto, Masahiro Kurosaka.
Abstract
Intervertebral disc degeneration and associated spinal disorders including low back pain are a leading source of morbidity and a major cause of work disability as well as increased health care costs. Recent advance of molecular biology enable us to utilize these new techniques for understanding disc cell function and mechanisms of disc degeneration. Furthermore, these new technology may open novel therapeutic strategy such as application of growth factors, stem cell therapy, and gene therapy to regenerate degenerated intervertebral discs.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15741683 DOI: CliCa0503399406
Source DB: PubMed Journal: Clin Calcium ISSN: 0917-5857